From: Unique perception of clinical trials by Korean cancer patients
Question | Answers | Patients in previous clinical trials (N=127) (%) | Patients never in clinical trial (N=548) (%) | p-value |
---|---|---|---|---|
Most influential factor for clinical trial participation | Using a new drug | 39(30.7) | 103(18.8) | 0.001 |
Economic benefit | 8(6.3) | 42(7.7) | Â | |
Contribute to medical development | 21(16.5) | 98(17.9) | ||
Physician’s recommendation | 37(29.1) | 144(26.3) | ||
No other treatment option | 19(15.0) | 159(29.0) | ||
Other | 3(2.4) | 2(0.4) | ||
Most influential factor for refusal to participate | Negative perception of clinical trials | 28(22.0) | 165(30.1) | 0.019 |
Unconfirmed treatment | 65(51.2) | 255(46.5) | Â | |
Frequent hospital visits | 8(6.3) | 45(8.2) | ||
Prefers standard treatment | 21(16.5) | 80(14.6) | ||
Other reasons | 5(4.9) | 3(0.6) |